Acasti Pharma Provides Fiscal 2019 Year-End Business Update

Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition

Fourth Quarter and Fiscal 2019 Earnings Conference Call

Jun 26, 2019 • 1:00 pm EDT

20th Annual B. Riley FBR Institutional Investor Conference

May 22, 2019 • 9:00 am PDT